Robin Roth joined Case CCC in June 2025 as the Clinical Research Office (CRO) director. Robin supports Case CCC's CRO by collaborating with the medical director, associate director, and deputy associate director for clinical research. She coordinates and oversees all clinical research within the center, engaging entities conducting patient-based research through hospital and institution-based Clinical Trial Units (CTUs). Robin also ensures compliance with the Cancer Center Support Grant (CCSG) and develops strategies and policies for coordinated clinical trial activity across consortium institutions (Seidman Cancer Center-University Hospitals and the Taussig Cancer Center-Cleveland Clinic). Additional responsibilities include the oversight of the Protocol Review and Monitoring Committee (PRMC) and the Data Safety and Monitoring Plan, including clinical trial audits and federal reporting to the National Cancer Institute (NCI), Food and Drug Administration, and Clinical Trials.gov. As CRO director, Robin works closely with cancer center leaders to develop priorities for programmatic and infrastructure resources as well as review and allocate internal funding for clinical research pilot projects.
Robin graduated from Kent State University with a Bachelor of Science in Nursing and maintains certifications in Critical Care Nursing (CCRN) and Clinical Research (CCRC). With 28 years of clinical research and nursing experience, her roles have included research coordinator, clinical research nurse, research nurse manager, and system director of the Clinical Research Center at Summa Health. She possesses comprehensive knowledge of ICH/GCP and federal regulations governing the conduct of Phase 2, 3, and post-market clinical trials for both drug and device investigational products across multiple specialties. She is passionate about clinical research education, research compliance, and ensuring the highest level of subject safety, data integrity, and clinical excellence in research trials.